P71 A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM)

Saved in:
Bibliographic Details
Title: P71 A randomised, double-blinded, placebo-controlled pilot study assessing the safety and tolerability of Arimoclomol in sporadic inclusion body myositis (IBM)
Authors: Machado, P., Miller, A., Parton, M., Dewar, L., Holton, J.L., Dimachkie, M., Herbelin, L., Greensmith, L., Barohn, R., Hanna, M.G.
Source: Neuromuscular Disorders. Mar2011 Supplement 1, Vol. 21, pS27-S27. 1p.
Database: Academic Search Ultimate
Description
ISSN:09608966
DOI:10.1016/S0960-8966(11)70090-6